A Gram Research analysis of 20,404 Danish people found that vitamin D levels measured at birth showed no association with the risk of developing autoimmune diseases like type 1 diabetes, rheumatoid arthritis, or celiac disease later in life. Babies with higher vitamin D levels had essentially the same autoimmune disease risk as those with lower levels, with only a 7% increase per standard deviation that wasn’t statistically significant. Even genetic variations affecting vitamin D status didn’t predict autoimmune disease risk, suggesting neonatal vitamin D is not a major factor in these conditions.
A large Danish study tracked over 20,000 people born between 1981 and 2005 to see if vitamin D levels at birth could predict autoimmune diseases later in life. Researchers measured vitamin D in newborn blood samples and followed participants for years, looking for nine different autoimmune conditions including type 1 diabetes, rheumatoid arthritis, and celiac disease. Surprisingly, babies with higher or lower vitamin D levels had the same risk of developing these diseases as adults. The findings suggest that vitamin D at birth isn’t a major factor in whether someone develops autoimmune disorders, challenging the idea that early vitamin D is protective against these conditions.
Key Statistics
A 2026 Danish cohort study of 20,404 people found that neonatal vitamin D levels showed no meaningful association with autoimmune disease risk, with a hazard ratio of 1.07 (95% CI: 0.99-1.15) per standard deviation increase.
Among 20,404 Danish individuals tracked from birth, 757 people (3.7%) developed an autoimmune disorder, but neonatal vitamin D-binding protein levels were not associated with disease risk (HR: 0.99 per SD increase).
Genetic predictors of vitamin D status did not predict autoimmune disease risk in a 2026 Danish study of over 20,000 people, with hazard ratios of 1.04 for vitamin D genetics and 0.98 for vitamin D-binding protein genetics.
A 2026 population-based cohort study found that neonatal vitamin D levels showed no association with any of nine specific autoimmune disorders studied, including multiple sclerosis, type 1 diabetes, and celiac disease.
The Quick Take
- What they studied: Whether vitamin D levels measured in newborn babies could predict the development of autoimmune diseases (like type 1 diabetes, rheumatoid arthritis, and celiac disease) later in life
- Who participated: 20,404 Danish people born between 1981 and 2005, with vitamin D measured from dried blood spots collected at birth. About 3.7% (757 people) developed an autoimmune disorder during follow-up
- Key finding: Neonatal vitamin D levels showed no meaningful association with autoimmune disease risk. For every standard increase in vitamin D, the risk of autoimmune disease increased by only 7% (95% CI: 0.99-1.15), which is not statistically significant
- What it means for you: If you’re a parent worried that your baby’s vitamin D level at birth will determine their autoimmune disease risk, this research suggests that’s not the case. However, this doesn’t mean vitamin D is unimportant for other aspects of health—just that neonatal levels alone don’t predict these specific diseases
The Research Details
Researchers used the iPSYCH2012 study, a large Danish population database, to follow people born over 24 years. They measured vitamin D (specifically 25-hydroxyvitamin D) and vitamin D-binding protein in blood samples taken from newborns and stored as dried spots on paper cards. They then tracked these individuals through Danish health registries to identify who developed nine specific autoimmune disorders: multiple sclerosis, rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, autoimmune thyroiditis, Graves’ disease, celiac disease, Crohn’s disease, and ulcerative colitis.
The researchers used a statistical method called Cox regression to calculate whether people with higher vitamin D levels at birth had different risks of developing these diseases compared to those with lower levels. They also looked at genetic predictors—essentially DNA variations that naturally make some people have higher or lower vitamin D levels—to see if genetics played a role.
This approach is powerful because it follows real people over decades and uses objective measurements from birth, avoiding the problems of studies that rely on people remembering their past or measuring vitamin D later in life when disease may already be developing.
This study design is important because it measures vitamin D at a fixed point in time (birth) before any autoimmune disease develops, which helps establish whether low vitamin D actually causes disease or if disease causes low vitamin D. Many previous studies measured vitamin D after people were already sick, making it impossible to know which came first. By using genetic predictors, the researchers also tested whether vitamin D itself matters or if other factors linked to vitamin D genetics are responsible.
This study has several strengths: it’s large (over 20,000 people), follows people for decades, uses objective measurements from birth records, and includes genetic analysis. It was published in a respected epidemiology journal. However, the study only included Danish people of European ancestry, so results may not apply to other populations. Additionally, only 3.7% of participants developed autoimmune disease, which is typical but means the researchers had limited cases to study for some individual diseases.
What the Results Show
Among 20,404 eligible individuals, 757 people (3.7%) developed an autoimmune disorder during follow-up. When researchers compared people with higher vitamin D levels at birth to those with lower levels, there was no meaningful difference in autoimmune disease risk. For every standard deviation increase in vitamin D (roughly 20-25 ng/mL), the hazard ratio was 1.07 (95% confidence interval: 0.99-1.15), meaning only a 7% increase in risk that could easily be due to chance.
Vitamin D-binding protein, a protein that carries vitamin D in the blood, also showed no association with autoimmune disease risk (HR: 0.99 per SD increase). The genetic predictors for both vitamin D levels and vitamin D-binding protein similarly showed no meaningful associations with autoimmune disease development.
When researchers looked at each of the nine autoimmune disorders individually—including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and celiac disease—the pattern remained consistent: neonatal vitamin D levels were not associated with disease risk for any of them.
The researchers also analyzed vitamin D levels by dividing participants into three groups (tertiles) based on their vitamin D concentrations rather than treating it as a continuous variable. This approach also showed no significant associations with autoimmune disease risk. The consistency of null findings across multiple analytical approaches strengthens the conclusion that neonatal vitamin D is not a major determinant of autoimmune disease risk.
This finding contrasts with some earlier research suggesting vitamin D deficiency increases autoimmune disease risk. However, those studies often measured vitamin D after disease onset or relied on observational data where causation couldn’t be proven. This Danish study’s prospective design (measuring vitamin D before disease develops) provides stronger evidence. The genetic analysis is particularly novel—by showing that genetic variations affecting vitamin D status don’t predict autoimmune disease, it suggests that even if vitamin D were important, it’s not the primary mechanism linking genetics to these diseases.
The study only included people of Danish/European ancestry, so findings may not apply to other populations with different genetic backgrounds or vitamin D metabolism. The relatively low rate of autoimmune disease (3.7%) means some individual diseases had few cases, limiting statistical power for those specific conditions. The study measured vitamin D only at birth; it’s possible that vitamin D at other critical periods (infancy, childhood, adolescence) could be more important. Finally, the study couldn’t account for environmental factors like sun exposure or dietary vitamin D intake after birth, which might influence disease risk.
The Bottom Line
Based on this research, neonatal vitamin D screening is not recommended as a way to predict or prevent autoimmune diseases. However, this doesn’t mean vitamin D is unimportant—it remains essential for bone health and other functions. Standard vitamin D recommendations for infants and children should continue to be followed based on other evidence. If you have a family history of autoimmune disease, focus on modifiable factors like maintaining healthy vitamin D levels throughout childhood and adolescence, rather than worrying about newborn vitamin D levels. Confidence level: High (based on large, well-designed study with consistent findings).
Parents concerned about autoimmune disease risk in their children should know this study suggests neonatal vitamin D isn’t a major factor. Healthcare providers can use this to avoid unnecessary vitamin D testing in newborns specifically for autoimmune disease prevention. Researchers studying autoimmune disease causes should look beyond early vitamin D levels to other factors. People with family histories of autoimmune disease shouldn’t assume their baby’s vitamin D at birth determines their risk.
This study doesn’t suggest any specific timeline for benefits because it found no protective effect of higher neonatal vitamin D. The follow-up period averaged many years (participants born 1981-2005 were tracked into adulthood), showing that even long-term follow-up revealed no association.
Frequently Asked Questions
Does low vitamin D at birth cause autoimmune diseases?
According to a 2026 Danish study of 20,404 people, neonatal vitamin D levels showed no meaningful association with autoimmune disease risk. Babies with lower vitamin D had essentially the same disease risk as those with higher levels, suggesting birth vitamin D isn’t a major cause.
Should parents worry about their baby’s vitamin D level and autoimmune disease?
Research shows neonatal vitamin D screening isn’t useful for predicting autoimmune disease risk. However, maintaining adequate vitamin D throughout childhood remains important for bone health and other functions based on separate evidence.
Can genetic vitamin D variations predict autoimmune disease?
A 2026 study found that genetic variations affecting vitamin D status did not predict autoimmune disease risk, with hazard ratios near 1.0. This suggests genetics related to vitamin D metabolism aren’t major autoimmune disease determinants.
Which autoimmune diseases were studied in this research?
The study examined nine autoimmune disorders: multiple sclerosis, rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, autoimmune thyroiditis, Graves’ disease, celiac disease, Crohn’s disease, and ulcerative colitis. Neonatal vitamin D showed no association with any of them.
Is vitamin D still important if it doesn’t prevent autoimmune diseases?
Yes. This study only examined autoimmune disease prevention. Vitamin D remains essential for bone health, immune function, and other processes. Standard vitamin D recommendations for infants and children should continue based on other evidence.
Want to Apply This Research?
- Rather than tracking neonatal vitamin D (which this study shows doesn’t predict autoimmune risk), users with family autoimmune disease history should track vitamin D levels during childhood and adolescence, along with other modifiable factors like sun exposure, diet, and infections
- If you have a family history of autoimmune disease, maintain adequate vitamin D intake through diet, supplements, or safe sun exposure throughout childhood and teen years—not just at birth. Log vitamin D-rich foods (fatty fish, fortified milk, egg yolks) and outdoor time weekly
- For families with autoimmune disease history, establish a pattern of monitoring vitamin D levels annually during childhood and adolescence rather than focusing on newborn levels. Track alongside other health markers and environmental factors that may influence autoimmune disease risk
This research suggests neonatal vitamin D is not associated with autoimmune disease risk, but it does not mean vitamin D is unimportant for overall health. Parents should continue following standard vitamin D recommendations for infants and children based on established guidelines. This study was conducted in a Danish population of European ancestry and may not apply to other populations. If you have concerns about autoimmune disease risk in your family, consult with a healthcare provider about evidence-based prevention strategies. This article is for informational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.